|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
6/14/2013
|
Bahcall Safi R
|
President and CEO
|
10,000
|
$4.06
|
0.50%
|
|
6/6/2013
|
Bahcall Safi R
|
President and CEO
|
10,000
|
$4.04
|
0.50%
|
|
6/6/2013
|
Kovner Bruce
|
Senior Executive Officer
|
738,900
|
$4.31
|
58.59%
|
|
6/5/2013
|
Kovner Bruce
|
Senior Executive Officer
|
756,000
|
$4.71
|
149.67%
|
|
6/5/2013
|
Vukovic Vojo
|
SVP, Chief Medical Officer
|
10,000
|
$4.58
|
39.61%
|
|
6/4/2013
|
WILSON ROBERT N
|
Director
|
10,000
|
$5.00
|
1.45%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
2,500
|
$7.03
|
0.88%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
5,500
|
$2.38
|
1.93%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
2,500
|
$2.38
|
0.86%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
5,500
|
$2.59
|
1.88%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
2,500
|
$2.59
|
0.84%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
5,500
|
$7.03
|
1.99%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
75,000
|
$10.84
|
37.13%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
5,500
|
$5.09
|
1.83%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
2,500
|
$5.09
|
0.82%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
5,000
|
$5.47
|
1.62%
|
|
1/23/2013
|
Gollust Keith R
|
Director
|
2,250
|
$5.47
|
0.72%
|
|
12/12/2012
|
KUFE DONALD W
|
Director
|
5,814
|
$8.60
|
48.72%
|
|
12/12/2012
|
Kovner Bruce
|
Senior Executive Officer
|
2,325,581
|
$8.60
|
245.39%
|
|
12/12/2012
|
Bahcall Safi R
|
President and CEO
|
10,000
|
$8.60
|
0.42%
|
|
12/12/2012
|
Gollust Keith R
|
Director
|
75,000
|
$8.60
|
2.89%
|
|
12/12/2012
|
WILSON ROBERT N
|
Director
|
58,140
|
$8.60
|
9.21%
|
|
11/29/2012
|
Singh Amar
|
Sr. VP, Chief Business Officer
|
-3,969
|
$8.21
|
-15.88%
|
|
11/14/2012
|
Kovner Bruce
|
Senior Executive Officer
|
10,500
|
$6.95
|
1.12%
|
|
11/12/2012
|
Bahcall Safi R
|
President and CEO
|
10,000
|
$7.12
|
0.42%
|
|
11/12/2012
|
Kovner Bruce
|
Senior Executive Officer
|
27,200
|
$6.89
|
2.99%
|
|
7/25/2012
|
KUFE DONALD W
|
Director
|
4,622
|
$6.49
|
63.21%
|
|
7/25/2012
|
WILSON ROBERT N
|
Director
|
100,000
|
$6.49
|
18.81%
|
|
7/25/2012
|
Bahcall Safi R
|
President and CEO
|
20,000
|
$6.49
|
0.85%
|
|
7/25/2012
|
Kovner Bruce
|
Senior Executive Officer
|
3,081,664
|
$6.49
|
62.57%
|
|
7/25/2012
|
Gollust Keith R
|
Director
|
770,416
|
$6.49
|
42.15%
|
|
6/29/2012
|
Bahcall Safi R
|
President and CEO
|
10,000
|
$5.34
|
0.43%
|
|
6/29/2012
|
Vukovic Vojo
|
SVP, Chief Medical Officer
|
3,000
|
$5.59
|
13.48%
|
|
6/29/2012
|
Gollust Keith R
|
Director
|
150,000
|
$5.35
|
8.94%
|
|
6/29/2012
|
Kovner Bruce
|
Senior Executive Officer
|
910,000
|
$5.45
|
15.41%
|
|
6/18/2012
|
Rieder Wendy E
|
VP, IP and Legal, Gen. Counsel
|
7,170
|
$2.49
|
36.17%
|
|
6/18/2012
|
Rieder Wendy E
|
VP, IP and Legal, Gen. Counsel
|
-7,170
|
$6.00
|
-26.56%
|
|
6/4/2012
|
Rieder Wendy E
|
VP, IP and Legal, Gen. Counsel
|
7,170
|
$2.49
|
36.17%
|
|
6/4/2012
|
Rieder Wendy E
|
VP, IP and Legal, Gen. Counsel
|
-7,170
|
$5.50
|
-26.56%
|
|
3/1/2012
|
Ehrlich Keith S
|
VP, Fin. and Admin., CFO
|
-4,397
|
$4.70
|
-20.01%
|
|
3/1/2012
|
Koya Keizo
|
Sr. VP, Drug Development
|
-6,844
|
$4.70
|
-34.49%
|
|
3/1/2012
|
Vukovic Vojo
|
SVP, Chief Medical Officer
|
-2,555
|
$4.70
|
-10.30%
|
|
1/6/2012
|
Kovner Bruce
|
Senior Executive Officer
|
1,136,363
|
$4.40
|
23.82%
|
|
12/7/2011
|
Kovner Bruce
|
Senior Executive Officer
|
11,059
|
$3.95
|
0.21%
|
|
11/29/2011
|
Kovner Bruce
|
Senior Executive Officer
|
8,844
|
$3.96
|
0.17%
|
|
11/25/2011
|
Kovner Bruce
|
Senior Executive Officer
|
25,016
|
$3.94
|
0.48%
|
|
11/23/2011
|
Kovner Bruce
|
Senior Executive Officer
|
7,547
|
$3.98
|
0.14%
|
|
11/22/2011
|
Kovner Bruce
|
Senior Executive Officer
|
453
|
$3.96
|
0.01%
|
|
11/21/2011
|
Kovner Bruce
|
Senior Executive Officer
|
33,640
|
$3.84
|
0.65%
|
|
11/18/2011
|
Kovner Bruce
|
Senior Executive Officer
|
21,000
|
$3.71
|
0.41%
|
|
9/12/2011
|
Kovner Bruce
|
Senior Executive Officer
|
43,085
|
$3.82
|
0.84%
|
|
9/9/2011
|
Kovner Bruce
|
Senior Executive Officer
|
110,149
|
$3.77
|
2.20%
|
|
9/6/2011
|
Kovner Bruce
|
Senior Executive Officer
|
50,400
|
$3.80
|
1.02%
|
|
9/2/2011
|
Kovner Bruce
|
Senior Executive Officer
|
46,057
|
$3.89
|
0.94%
|
|
9/2/2011
|
Vukovic Vojo
|
SVP, Chief Medical Officer
|
2,188
|
$4.00
|
9.67%
|
|
9/1/2011
|
Vukovic Vojo
|
SVP, Chief Medical Officer
|
312
|
$4.07
|
1.40%
|
|
8/23/2011
|
Kovner Bruce
|
Senior Executive Officer
|
5,167
|
$3.72
|
0.11%
|
|
8/22/2011
|
Kovner Bruce
|
Senior Executive Officer
|
10,597
|
$3.77
|
0.22%
|
|
8/18/2011
|
Kovner Bruce
|
Senior Executive Officer
|
3,303
|
$3.79
|
0.07%
|
|
8/10/2011
|
Kovner Bruce
|
Senior Executive Officer
|
33,978
|
$3.70
|
0.70%
|
|
8/9/2011
|
Kovner Bruce
|
Senior Executive Officer
|
52,464
|
$3.71
|
1.09%
|
|
8/8/2011
|
Kovner Bruce
|
Senior Executive Officer
|
41,700
|
$3.77
|
0.88%
|
|
4/25/2011
|
Koya Keizo
|
Sr. VP, Drug Development
|
-10,000
|
$6.00
|
-33.51%
|
|
4/20/2011
|
Koya Keizo
|
Sr. VP, Drug Development
|
-10,000
|
$5.60
|
-25.10%
|
|
4/14/2011
|
Kovner Bruce
|
Senior Executive Officer
|
1,431,493
|
$4.89
|
43.04%
|
|
4/14/2011
|
Gollust Keith R
|
Director
|
100,000
|
$4.89
|
6.34%
|
|
4/14/2011
|
WILSON ROBERT N
|
Director
|
50,000
|
$4.89
|
10.58%
|
|
3/15/2011
|
Bahcall Safi R
|
President and CEO
|
5,000
|
$4.45
|
0.21%
|
|
3/1/2011
|
Vukovic Vojo
|
SVP, Chief Medical Officer
|
-2,617
|
$5.32
|
-14.85%
|
|
3/1/2011
|
Koya Keizo
|
Sr. VP, Drug Development
|
-18,270
|
$5.23
|
-35.64%
|
|
3/1/2011
|
Ehrlich Keith S
|
VP, Fin. and Admin., CFO
|
-2,537
|
$5.51
|
-12.62%
|
|
3/1/2011
|
Rieder Wendy E
|
VP, IP and Legal, Gen. Counsel
|
-5,284
|
$5.25
|
-25.51%
|